View Older Stories View More Recent Stories
-
ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million
-
Walt Disney (DIS) PT, Estimates at Jefferies on Slowing Growth
-
Dunkin (DNKN) Estimates Trimmed Ahead of Earnings - RBC
-
Gouged California Drivers Bankroll Chevron's Best US Refining Year Ever, says Consumer Watchdog
-
Boralex closes financing of €63 million in France
-
Valeant defends price hikes after Clinton remarks; shares jump
-
Express Scripts (ESRX) Aims to Clamp Down on High Drug Prices; Excludes Valeant's (VRX) Glumetza from Formulary
-
Kadant (KAI) Receives $7M in Orders from Two North American Paper Producers
-
Kadant Awarded $7 Million in Orders for Fiber Processing Systems
-
U of M Sentiment (Jan. F) 92 vs 93 Expected
-
Altus Group Releases Results of 2015 Real Estate Review
-
Colgate-Palmolive sales miss on strong dollar, weak LatAm demand
-
CONSOL Energy Reports Fourth Quarter Results; Net Income of $30 million, or $0.13 per Diluted Share; Second Pennsylvania Dry Utica Shale Well (GH 9) 24-Hour Initial Production (IP) Rate of 61.9 MMcf p
-
Praxair Reports Full-Year and Fourth-Quarter 2015 Results
-
Whirlpool Corporation Reports Record Fourth-Quarter And Full-Year 2015 Results
-
Manhattan and Brooklyn Prices End 2015 at Record Highs
-
Bank of Japan to meet as market swings complicate policy call
-
Clinton targets Valeant price hikes in campaign appearance
-
John B. Sanfilippo & Son, Inc. Second Quarter EPS Increased by 42.7% to a Second Quarter Record $1.07 per Share Diluted
-
Optimal Blue Recognized for Industry-Changing Innovations
-
Deluxe Reports Fourth Quarter 2015 Financial Results
-
Meritage Homes Reports Fourth Quarter 2015 Results, Including 23% Order Growth, 11% Increase in Home Closing Revenue and 6% Increase in Diluted EPS at $1.26
-
Alliqua Biomedical Announces Partnership With Human Longevity Inc., Under Existing Licensing Agreement
-
Airgas Reports Fiscal 2016 Third Quarter Earnings
-
Mead Johnson Nutrition Delivers Earnings Per Share Above Guidance for Fourth Quarter and Full Year 2015; Provides 2016 Guidance
-
Caterpillar Reports 2015 Fourth-Quarter and Full-Year Financial Results; Provides Outlook for 2016
-
Hubbell Reports Fourth Quarter Results: Sales of $830 Million and Earnings Per Diluted Share of $1.06, Including $0.17 of Reclassification Costs
-
Lancaster Colony Reports Second Quarter Sales And Earnings
-
Altria Reports 2015 Fourth-Quarter and Full-Year Results; Delivers Full-Year Adjusted Diluted EPS Growth of 8.9%
-
The Sherwin-Williams Company Reports 2015 Year-end Financial Results
-
Harley-Davidson Reports Fourth Quarter And Full-Year 2015 Results
-
Oshkosh Corporation Reports 2016 First Quarter Results
-
INGREDION INCORPORATED REPORTS SOLID FOURTH QUARTER 2015 RESULTS
-
TrendForce Reports Worldwide LCD TV Shipments Down 0.6% in 2015 While China’s TCL and Hisense Saw Growth Despite Headwinds
-
PulteGroup Reports Financial Results For 2015 Fourth Quarter
-
Online Bike Retailer Price Point Announces Limited Time Free Shipping Test
-
6.4 Million U.S. Properties Seriously Underwater at End of 2015, Down 616,000 From Year Ago and Half of Peak in Q2 2012
-
Swaps clearing houses can pose contagion risks: U.S. monitor
-
S&P Capital IQ Equity Research Forecasts Volatility Ahead in 2016 Healthcare Sector Outlook
-
Sprint (S) Raising Guidance and Cutting Costs - FBR
-
The Journal of Investment Management (JOIM) and New Frontier Advisors Name 2015 Harry M. Markowitz Award Winners
-
UPDATE: Oppenheimer Upgrades Sprint (S) to Perform
-
UPDATE: Canaccord Genuity Downgrades Regeneron Pharma (REGN) to Hold on Slowing EYLEA Growth and Lower Praluent Revenues
-
Alliqua (ALQA) Enters National Group Purchasing Agreement with HealthTrust
-
Alliqua BioMedical Announces Agreement With HealthTrust
-
Tupperware Brands Reports Fourth Quarter 2015 Results; Declares Regular Quarterly Dividend
-
RPC, Inc. Reports Fourth Quarter 2015 Financial Results
-
FCA Closed 2015 With a Strong Performance Well in Excess of Full-year Guidance
-
BOJ seen to favor standing pat, post-Fed markets may sway debate
-
Australia inflation restrained, no trigger on rates

